Combination therapy can delay resistance of lung cancer cells

1 year ago 77

A specific genetic alteration, known as an ALK fusion, drives non-small cell lung cancer in some patients. This abnormality leads to excessive activity of the ALK protein, a key cancer promoter. These ...

1. Homepage
2. Lung Cancer
3. Combination therapy can delay resistance of lung cancer cells